Alyeska Investment Group’s Affimed AFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-35,000
Closed -$186K 560
2024
Q1
$186K Hold
35,000
﹤0.01% 442
2023
Q4
$219K Hold
35,000
﹤0.01% 472
2023
Q3
$167K Hold
35,000
﹤0.01% 463
2023
Q2
$209K Hold
35,000
﹤0.01% 526
2023
Q1
$261K Hold
35,000
﹤0.01% 430
2022
Q4
$434K Hold
35,000
﹤0.01% 377
2022
Q3
$721K Sell
35,000
-25,000
-42% -$695K 0.01% 350
2022
Q2
$1.66M Buy
+60,000
New +$2.05M 0.02% 424
2015
Q3
Sell
-14,059
Closed -$1.89M 460
2015
Q2
$1.89M Buy
14,059
+7,807
+125% +$749K 0.02% 354
2015
Q1
$394K Buy
6,252
+459
+8% +$28.4K 0.01% 476
2014
Q4
$359K Sell
5,793
-4,207
-42% -$240K 0.01% 459
2014
Q3
$630K Buy
+10,000
New +$624K 0.01% 353

Other funds holding AFMD

Alyeska Investment Group's AFMD Position: Q2 2024 in Review

Alyeska Investment Group sold out of Affimed (AFMD) in Q2 2024, closing a stake of 35,000 shares — an estimated $186K sold.

Alyeska Investment Group first reported a position in AFMD in Q3 2014 and held it in 12 quarters. The position peaked at $1.89M in Q2 2015. 44 funds tracked by Wall St. Rank hold AFMD as of Q2 2024.

  • Alyeska Investment Group reported no remaining Affimed position as of Q2 2024 after selling out during the quarter.
  • Alyeska Investment Group sold 35,000 Affimed shares in Q2 2024, an estimated $186K.
  • Alyeska Investment Group first reported a position in Affimed in Q3 2014 and held it in 12 quarters.
  • Alyeska Investment Group's Affimed position peaked at $1.89M in Q2 2015.
  • 44 funds tracked by Wall St. Rank held Affimed as of Q2 2024.

Based on Alyeska Investment Group's 13F filing for Q2 2024, filed 14 Aug 2024.